Reborna Biosciences

Developer of RNA-based drugs to treat rare genetic diseases

placeKanagawa, Kanto, Japan calendar_todayFounded 2018 groups6 employees language rebornabiosciences.com

Social engagement

Social engagement: 176 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Nissay Capital.

Investor typeCountShare
Venture capital450%
Angel & family office113%
Other / undisclosed338%

Recent activity

20 Oct 2025
Partnership
JLABS Singapore
Coming soon